Plerixafor-moblized Stem Cells Alone Are Capable of Inducing Early Engraftment Across the MHC-haploidentical Canine Barrier
Overview
Affiliations
Humbert O, Chan F, Rajawat Y, Torgerson T, Burtner C, Hubbard N Blood Adv. 2018; 2(9):987-999.
PMID: 29720491 PMC: 5942001. DOI: 10.1182/bloodadvances.2018016451.
Chang J, Graves S, Butts-Miwongtum T, Sale G, Storb R, Mathes D Transplantation. 2016; 100(12):e120-e127.
PMID: 27861292 PMC: 5453180. DOI: 10.1097/TP.0000000000001496.
Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.
Chang Y, Huang X Bone Marrow Transplant. 2014; 49(7):873-9.
PMID: 24566712 DOI: 10.1038/bmt.2014.19.
Physiology and pharmacology of plerixafor.
Fricker S Transfus Med Hemother. 2013; 40(4):237-45.
PMID: 24179472 PMC: 3776399. DOI: 10.1159/000354132.
Chen Y, Fukuda T, Thakar M, Kornblit B, Storer B, Santos E Cytotherapy. 2011; 13(10):1269-80.
PMID: 21846291 PMC: 3195840. DOI: 10.3109/14653249.2011.586997.